Hydrolyzed guar gum (DrugBank: Guar gum)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 6 | Parkinson disease | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04569656 (ClinicalTrials.gov) | February 2, 2016 | 24/9/2020 | Treatment of Chronic Constipation in Parkinson's Disease | Pilot Study for the Evaluation of the Parameters of Activity of a Preparation of PHGG and Sodium Hyaluronate in Chronic Constipation in Patients With Parkinson's Disease | Parkinson Disease | Drug: hydrolyzed guar gum | IRCCS San Raffaele | NULL | Completed | 18 Years | N/A | All | 34 | Phase 2 | Italy |